Показати скорочений опис матеріалу

dc.contributor.author Olkhovych, N. V. en
dc.contributor.author Pichkur, N. A. en
dc.contributor.author Ivanova, T. P. en
dc.contributor.author Gorovenko, N. G. en
dc.contributor.author Sinchuk, N. I. en
dc.date.accessioned 2018-02-26T12:39:14Z
dc.date.available 2018-02-26T12:39:14Z
dc.date.issued 2011
dc.identifier.citation Clinical presentation of a patient with a severe form of pompe disease / N. I. Sinchuk, N. V. Olkhovych, N. A. Pichkur [et al.] // Clinical Therapeutics. - 2011.- № 33. - Р. 13. en
dc.identifier.uri https://dspace.vnmu.edu.ua/123456789/2036
dc.description.abstract Pompe disease is a lysosomal storage disorder resulting from a deficiency of lysosomal acid a-gluco-sidase (GAA). Pompe disease has been classified as infantile onset or late onset; a single disease with a variable age at onset and rate of progression. The most severe form is typically diagnosed in infants between 3 and 5 months of age during the assessment of a respiratory infection, cardiomegaly, or hypotonia. In natural history studies in infants, the gap between diagnosis and ventilator use or death was 1 to 2 months; nearly all infants died by the age of 18 months. en
dc.language.iso en en
dc.subject pompe disease en
dc.subject clinical case en
dc.title Clinical presentation of a patient with a severe form of pompe disease en
dc.type Article en


Файли цього елементу

Даний матеріал зустрічається у наступних зібраннях

Показати скорочений опис матеріалу